Kagawa-ken, Japan

Noriko Mizobuchi


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Noriko Mizobuchi: Innovator in Dermatological Treatments

Introduction

Noriko Mizobuchi is a prominent inventor based in Kagawa-ken, Japan. She has made significant contributions to the field of dermatology through her innovative inventions. With a total of two patents to her name, Mizobuchi has focused on developing effective treatments for skin injuries.

Latest Patents

Mizobuchi's latest patents include an "Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation." This invention aims to enhance the delivery of medication through the skin while minimizing irritation. Another notable patent is a method for treating skin injuries, which involves topically applying a drug for the treatment of hard-to-heal conditions such as bedsores. This drug comprises acetylsalicylic acid as an active ingredient and can be used in the form of a topical preparation or administered orally.

Career Highlights

Mizobuchi works at Teikoku Seiyaku Kabushiki Kaisha, a company known for its commitment to pharmaceutical innovation. Her work has been instrumental in advancing treatments for skin conditions, showcasing her dedication to improving patient care.

Collaborations

Mizobuchi collaborates with talented coworkers, including Sayuri Seto and Ryoji Konishi. Their combined expertise contributes to the success of their projects and the development of new therapeutic solutions.

Conclusion

Noriko Mizobuchi's contributions to dermatological treatments through her patents reflect her innovative spirit and commitment to healthcare. Her work continues to impact the field positively, providing new options for patients with challenging skin conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…